Skip to search
Skip to main content
Back to Search
Start Over
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
Authors :
Neurologen Brain Verstegen, Niels J.M. Hagen, Ruth R. Kreher, Christine Kuijper, Lisan H. van den Dijssel, Jet Ashhurst, Thomas Kummer, Laura Y.L. Cabeza, Virginia Palomares Steenhuis, Maurice Duurland, Mariël C. de Jongh, Rivka van der Schoot, C. Ellen Konijn, Veronique A.L. Mul, Erik Kedzierska, Katherine van Dam, Koos P.J. Stalman, Eileen W. Boekel, Laura Wolbink, Gertjan Tas, Sander W. Killestein, Joep Rispens, Theo Wieske, Luuk Kuijpers, Taco W. Eftimov, Filip van Kempen, Zoé L.E. van Ham, S. Marieke ten Brinke, Anja van de Sandt, Carolien E. T2B! immunity against SARS-CoV-2 study group Neurologen Brain Verstegen, Niels J.M. Hagen, Ruth R. Kreher, Christine Kuijper, Lisan H. van den Dijssel, Jet Ashhurst, Thomas Kummer, Laura Y.L. Cabeza, Virginia Palomares Steenhuis, Maurice Duurland, Mariël C. de Jongh, Rivka van der Schoot, C. Ellen Konijn, Veronique A.L. Mul, Erik Kedzierska, Katherine van Dam, Koos P.J. Stalman, Eileen W. Boekel, Laura Wolbink, Gertjan Tas, Sander W. Killestein, Joep Rispens, Theo Wieske, Luuk Kuijpers, Taco W. Eftimov, Filip van Kempen, Zoé L.E. van Ham, S. Marieke ten Brinke, Anja van de Sandt, Carolien E. T2B! immunity against SARS-CoV-2 study group
Publication Year :
2024
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1457899244
Document Type :
Electronic Resource